Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Polyquaternium-Preserved DuoTrav APS in Glaucoma/Ocular Hypertension
NCT00928590Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Jul 2009
- Primary completion
- Nov 2010
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
A Phase 3 trial of travoprost, timolol in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Jul 2009; status: completed.
02
Drugs
travoprosttimolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00928590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00928590.